Global Market for Enteric Disease Technologies to Reach $14.6 Billion in 2018; Emerging Economies to Witness Rapid Growth

December 11, 2014

Wellesley, Mass., December 11, 2014 – BCC Research reveals that the rising incidence of enteric diseases, along with increasing global population, availability of the treatment technologies and growing health awareness worldwide has consequently led to the surging use of enteric disease technologies in the past few years. The global market for enteric disease diagnostics and testing was valued at $4.6 billion in 2013 and is expected to grow at a compound annual growth rate (CAGR) of 25.8% from 2013 to 2018, to reach nearly $14.6 billion in 2018.

In developing countries the main factors for the spread and acceleration in enteric diseases are global warming, unsatisfactory drainage, sanitation, overcrowding and poor hygiene. Many of these are the major factors for the rapid rise in worldwide enteric infection. With the development of new vaccines for prevention, the sales of enteric disease technologies are anticipated to climb in the near future. In addition, global warming and travel are leading to an advance in the transmission of these diseases and also a rise in awareness. All of this is leading to a healthy boost in the market’s size.

In terms of region, the markets of Asia-Pacific, Africa, and Latin America are predicted to grow swiftly in the next few years. This can largely be attributed to the introduction of rapid dipstick tests. These tests can be used by the patient, which is another factor for the anticipated growth in this space. In addition, these countries’ economies are improving, and lower healthcare costs are expected to help the market’s growth along with new strains being introduced.

“The global rise in temperatures has led to survival of causative agents and further spread,” says BCC Research healthcare analyst Usha Nagavarapu. “There is a critical need for a point of care, and improved, specific diagnostic technologies in this market.”

 Enteric Disease Testing and Treatment: Technologies and Global Markets is an exhaustive study on the global enteric or gastrointestinal market with statistics regarding incidence and analysis of testing diagnostic technologies, vaccine development, latest trends, market structure, market size, key drug segments and trends in technology. 

To Contact us, click here  

Editors and reporters who wish to speak with the analyst should contact Steven Cumming at steven.cumming@bccresearch.com.

Enteric Disease Testing and Treatment: Technologies and Global Markets( HLC166A )
Publish Date: Oct 2014    

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.